CorMedix Inc. (NASDAQ: CRMD)
$11.4800
+0.8500 ( +8.00% ) 810.2K
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Market Data
Open
$11.4800
Previous close
$10.6300
Volume
810.2K
Market cap
$694.75M
Day range
$10.6200 - $11.6000
52 week range
$2.5700 - $13.8500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Oct 30, 2024 |
10-q | Quarterly Reports | 54 | Oct 30, 2024 |
def | Proxies and info statements | 5 | Oct 08, 2024 |
10-q | Quarterly Reports | 55 | Aug 14, 2024 |
8-k | 8K-related | 15 | Aug 14, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
10-q | Quarterly Reports | 52 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |